References
Use of Hormone Therapy for Menopausal Symptoms
- Hing E, Brett KM. Changes in U.S. prescribing patterns of menopausal hormone therapy, 2001-2003. Obstet Gynecol 2006;108:33-40.
- Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. JAMA 1998;280(7):605-13.
- The Million Women Study Collaborators. The Million Women Study: A confidential national study of women’s health. Accessed May 6, 2008.
- The Nurses' Health Study. Accessed May 6, 2008.
- Nelson HD, Humphrey LL, LeBlanc E, Miller J, Takano L, Chan BKS, et al. Postmenopausal hormone replacement therapy for primary prevention of chronic conditions. Summary of the evidence for the U.S. Preventive Services Task Force. Agency for Healthcare Research and Quality, Rockville, MD. Accessed May 6, 2008.
- North American Menopause Society. Estrogen and progestogen use in peri- and postmenopausal women: March 2007 position statement of The North American Menopause Society. Menopause 2007;14:168-82.
- Institute for Clinical Systems Improvement. Health care guideline: Menopause and hormone therapy (HT): collaborative decision-making and management. Accessed May 6, 2008.
- Keenan NL, Mark S, Fugh-Berman A, Browne D, Kaczmarczyk J, Hunter C. Severity of menopausal symptoms and use of both conventional and complementary/alternative therapies. Menopause 2003;10:507-15.
- The National Institutes of Health. NIH state-of-the-science conference statement on management of menopause-related symptoms. Accessed May 6, 2008.
- Burger H, Woods NF, Dennerstein L, Alexander JL, Kotz K, Richardson G. Nomenclature and endocrinology of menopause and perimenopause. Expert Rev Neurother 2007;7:S35-S43.
- Wylie-Rosett J. Menopause, micronutrients, and hormone therapy. Am J Clin Nutr 2005;81:1223S-31S.
- Gold EB, Block G, Crawford S, Lachance L, FitzGerald G, Miracle H, et al. Lifestyle and demographic factors in relation to vasomotor symptoms: baseline results from the Study of Women’s Health Across the Nation. Am J Epidemiol 2004;159:1189-99.
- Li C, Samsioe G, Borgfeldt C, Lidfeldt J, Agardh CD, Nerband C. Menopause-related symptoms; what are the background factors? A prospective population-based cohort study of Swedish women (The Women’s Health in Lund Area study). Am J Obstet Gynecol 2003;189:1646-53.
- Pockaj BA, Gallagher JG, Loprinzi CL, Stella PJ, Barton DL, Sloan JA, et al. Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1. J Clin Oncol 2006;24:2836-41.
- Lehmann-Willenbrock E, Riedel HH. [Clinical and endocrinologic studies of the treatment of ovarian insufficiency manifestations following hysterectomy with intact adnexa]. Zentralbl Gynakol 1988;110:611-8.
- Kronenberg F, Fugh-Berman A. Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials. Ann Intern Med 2002;137:805-13.
- Cheema D, Coomarasamy A, El-Toukhy T. Non-hormonal therapy of post-menopausal vasomotor symptoms: a structured evidence-based review. Arch Gynecol Obstet 2007;276:463-9.
- North American Menopause Society. Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society. Menopause 2004;11:11-33.
- Saskatoon City Hospital and the British Columbia Community Drug Utilization Program. HRT alternatives in light of the WHI. University of Saskatchewan, 2002. Accessed May 2, 2008.
- Goldenberg NM, Wang P, Glueck CJ. An observational study of severe hypertriglyceridemia, hypertriglyceridemic acute pancreatitis, and failure of triglyceride-lowering therapy when estrogens are given to women with and without familial hypertriglyceridemia. Clin Chim Acta 2003;332:11-9.
- Kelley C. Estrogen and its effect on vaginal atrophy in post-menopausal women. Urol Nurs 2007;27(1):40-5.
- Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med 1993;329:753-6.
